Spinogenix, Inc.
PrivateLast Round
Seed Round
Mar 9, 2026
Total Funding Raised
$4.85M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Spinogenix, Inc. is a clinical-stage biopharmaceutical company developing novel small molecule drugs designed to regenerate synapses and reverse declines in cognitive and motor function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spinogenix, Inc. Comparables
Compare Spinogenix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gate Neurosciences | 79% | |
| PharmatrophiX | 79% | |
| PridCor Therapeutics | 79% |
Spinogenix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 9, 2026 | ||||
| Grant | Sep 12, 2023 | ||||
| Grant | Jul 11, 2023 | ||||
| Grant | Jan 5, 2021 | ||||
| Grant | May 1, 2018 |
Spinogenix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| U.S. Department of Defense | Grant |
| U.S. Department of War | Grant |
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 63% MoM, reaching 5.4K.
- Mar 26, 2026
Presented at the Schizophrenia International Research Society (SIRS) 2026 Annual Congress.
Recent news
Latest coverage and updates
- partners_withOct 15, 2026
Spinogenix, Inc. and Cincinnati Children's Hospital Medical Center conduct joint research supporting biomarker-enriched recruitment for an autism trial.
Spinogenix, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Spinogenix, Inc.'s valuation, stock price, and market status.
Is Spinogenix, Inc. a public or private company?
Spinogenix, Inc. is a private company.
What is the current stock price of Spinogenix, Inc.?
Spinogenix, Inc. is a private company, so its shares have no public market price. Caplight tracks Spinogenix, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Spinogenix, Inc. worth (valuation)?
Valuation information for Spinogenix, Inc. is not publicly available.
Can I buy Spinogenix, Inc. stock?
Spinogenix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Spinogenix, Inc.'s last funding round?
Spinogenix, Inc.'s most recent funding round was Seed Round on March 9, 2026.
Who are the main investors in Spinogenix, Inc.?
Key investors in Spinogenix, Inc. include U.S. Department of Defense, U.S. Department of War, National Institute on Aging.
Will Spinogenix, Inc. IPO soon?
No public IPO plans have been announced for Spinogenix, Inc..
How can I track Spinogenix, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Spinogenix, Inc.'s shares on secondary markets.